Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Cytonus is a biotech company combining AI-driven drug discovery together with a class defining drug-delivery platform called the Cargocyte
Medical Device, SaMD, Software, Neurotechnology, Biofeedback, Neurofeedback
Partillion Bioscience is an early-stage life science company developing a functional single-cell analysis platform.
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain injury patients.
Integrated BioTherapeutics focuses on the discovery of novel vaccines and therapeutics for emerging infectious diseases.
SentiAR is a digital health company that offers a holographic AR platform for intraprocedural clinical use.
Thetis Pharmaceuticals is a biopharmaceutical company.
The digestive health platform of the future
Biotechnology company developing pharmaceutical therapies for nerve regeneration in the central nervous system.
Amplo Biotechnology is to develop multiple, potentially curative, Adeno-Associated Viral (AAV) therapies for the neuromuscular junction.
Bleep provides best new CPAP solution on the market.
Medcognetics is an IT company that provides cloud-based software-as-a-service leveraging artificial intelligence for the medical sector.
Advanced material, and manufacturing company focused on Chromatography and allied products
Phenomix Sciences is a biotechnology company that specializes in biotech, life science, metabolomics, and genomics.
Explore Interactive is a developer of augmented reality educational games
Platform tech for ultra-rapid, instrument-free, point-of-care assays that provide lab-grade precision under one minute anywhere
Curi Bio integrates human stem cells, systems, and AI-enabled data analytics for the development of new therapeutics.
IVOS Medical is a startup medical device specializing company in airway management.
CODA Biotherapeutics develops a chemogenetic platform designed to modulate neuronal activity.
Trace Biosciences creates fluorescence imaging agents for real-time nerve visualization during surgery.
Prapela is a noninvasive stimuation therapy that improves breathing and oxygenation in newborns.
Trethera is a biotechnology company that discovers and develops small molecules that control DNA replication and integrity.
HQ Science is a biotechnology company at the forefront of molecular diagnostics innovation.
CaroGen develops vaccine candidates targeting hepatitis B and C, and other viral agents.
National Institutes of Health has invested in 491 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
National Institutes of Health's top investment sectors include Health Care, Biotechnology, Medical, Medical Device, Pharmaceutical. The firm invests across 28 different industry categories.
Among tracked funding rounds, CODA Biotherapeutics received $28.0M in a Venture - Series Unknown round. National Institutes of Health's total known invested capital is $2.5B.
National Institutes of Health's average investment size is $5.9M across its portfolio of 491 companies.
Recent National Institutes of Health portfolio additions include Cytonus Therapeutics, Neurotype Inc., Partillion Bioscience, Astrocyte Pharmaceuticals, Integrated BioTherapeutics. These companies were founded in 2020 or later.